RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CBAY
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Cymabay Therapeutics Inc stock price ended at $32.48 on Thursday, after losing 0%.
(Updated on Mar 28, 2024)

Buy or Hold candidate since Jan 26, 2024 Gain 41.03% PDF

No changes to the price of Cymabay Therapeutics Inc stock on the last trading day (Thursday, 28th Mar 2024). During the last trading day the stock fluctuated 0% from a day low at $32.48 to a day high of $32.48. The price has been going up and down for this period, and there has been a 0.03% gain for the last 2 weeks.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $31.76 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 53.71% during the next 3 months and, with a 90% probability hold a price between $48.82 and $56.74 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CBAY Signals & Forecast

The Cymabay Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $32.48 and $31.93. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Sell
Special Signal Notification

Double Top Formation

Double Top Formation

Support, Risk & Stop-loss for Cymabay Therapeutics Inc stock

Cymabay Therapeutics Inc finds support from accumulated volume at $32.21 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

The Cymabay Therapeutics Inc stock is extremely overbought on RSI14 (87). This increases the short-term risk substantially.

Our recommended stop-loss: $31.42 (-3.26%) (This stock has low daily movements and this gives low risk. The RSI14 is 87 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (CBAY) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Cymabay Therapeutics Inc to open at $32.48, and during the day (based on 14 day Average True Range), to move between $32.31 and $32.65, which gives a possible trading interval of +/-$0.175 (+/-0.54%) up or down from last closing price. If Cymabay Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 1.08% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $32.21, some $0.270 (0.83%) from the current price of $32.48, our system finds the risk reward attractive.

Is Cymabay Therapeutics Inc stock A Buy?

Cymabay Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Cymabay Therapeutics Inc of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$32.48 ( 0%) $32.48

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CBAY

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 32.48 .
R2 32.48 .
R1 32.48 .
Current price: 32.48
Support S1 32.48 .
S2 32.48 .
S3 32.48 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 32.48
Support S1 32.21 -0.83%
S2 32.18 -0.92%
S3 32.12 -1.11%

FAQ

What is the symbol for Cymabay Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Cymabay Therapeutics Inc is CBAY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cymabay Therapeutics Inc Stock?
Cymabay Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Cymabay Therapeutics Inc Stock?
Cymabay Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cymabay Therapeutics Inc Stock.

What's the current price of Cymabay Therapeutics Inc Stock?
As of the end of day on the 2024-03-28, the price of an Cymabay Therapeutics Inc (CBAY) share was $32.48.

What is the 52-week high and low for Cymabay Therapeutics Inc Stock?
The 52-week high for Cymabay Therapeutics Inc Stock is $32.50 and the 52-week low is $7.26.

What is the market capitalization of Cymabay Therapeutics Inc Stock?
As of the 2024-03-28, the market capitalization of Cymabay Therapeutics Inc is 3.728B.

When is the next earnings date for Cymabay Therapeutics Inc?
The upcoming earnings date for Cymabay Therapeutics Inc is May 20, 2024.
Click to get the best stock tips daily for free!

About Cymabay Therapeutics Inc

Cymabay Therapeutics CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of primary biliary cholangitis (PBC), as well as has completed Phase 2b clinical study to treat patients with... CBAY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT